VRX-RET-E22-302

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRX-RET-E22-302, covering 2018-06-06 to 2018-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097 [Phase 3]